CLSI C50

Mass Spectrometry in the Clinical Laboratory: General Principles and Guidance, 1st Edition

This guideline provides a general understanding of mass spectrometry and the principles that dictate its application in the clinical laboratory. It includes guidance, references, and quality assurance markers that will assist with the implementation and correct operation of a mass spectrometry (MS) system for its many applications. Information on maintaining optimum performance, approaches to ensuring accurate and precise mass measurement, verification of methods, quality control of assays within and between instruments, instrument troubleshooting, sample preparation, interpretation of results, and limitations of the technology is included.

This document is available in electronic format only.

More Details

Member price:

List Price:

PDF Add to Cart

Details

Chairholder: Donald H. Chace, PhD

Date of Publication: October 29, 2007

Order Code PDF: CLSI C50AE
ISBN Number: 1-56238-648-4

Order Code Print: print not available

Edition: First

Pages: 112

CLSI C50 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

A CLSI-IFCC joint project.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2017. Because of its value to the laboratory community, it is being retained in CLSI’s library.

CLSI C50 Abstract

C50-A | Mass Spectrometry in the Clinical Laboratory: General Principles and Guidance, 1st Edition This guideline provides a general understanding of mass spectrometry and the principles that dictate its application in the clinical laboratory. It includes guidance, references, and quality assurance markers that will assist with the implementation and correct operation of a mass spectrometry (MS) system for its many applications. Information on maintaining optimum performance, approaches to ensuring accurate and precise mass measurement, verification of methods, quality control of assays within and between instruments, instrument troubleshooting, sample preparation, interpretation of results, and limitations of the technology is included. A CLSI-IFCC joint project. This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content. Chairholder: Donald H. Chace, PhD Organization: Pediatrix Screening Inc. Date of Publication: 10/29/2007 ISBN Number: 1-56238-648-4 Edition: First Edition Pages: 112 Preview Sample Pages Nonmember Price: $140.00 Membership discount will be applied at checkout. This document is available in electronic format only.